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Abstract 
Background: Renal papillary calcification is a compelling candidate risk factor for chronic kidney disease (CKD) and 
nephrolithiasis. Renal papillary density (RPD), as assessed by computed tomography (CT), is a potential marker for 
calcification that has not been well studied. We developed a protocol to measure RPD using CT scans and assessed its 
reproducibility in participants from the Framingham Heart Study.
Methods: We assessed RPD of right kidneys from a single abdominal CT slice in 100 representative participants from 
the Framingham Heart Study (47 % female, mean age 59.9 years) using a novel protocol. We selected the kidney slice 
with the most open sinus space and assessed RPD using the average of three 20 mm2 ellipses from upper, middle and 
lower papillary regions. Two different readers performed RPD measurements and the first reader repeated all meas-
urements to determine both intra- and inter-reader reproducibility, respectively.
Results: Of 100 total individuals included in the replication dataset, six were excluded for poor scan quality. Average 
RPD across all individuals was 48.7 ± 4.7 (range 38.7–61.7) Hounsfield Units (HU). The intra- and inter-reader correla-
tion coefficients were 0.86 and 0.79, respectively. Bland–Altman analysis suggested no systematic bias between the 
different reads.
Conclusion: Measuring RPD is practical and reproducible using MDCT scans from a small sample of a community-
based cohort.
Keywords: Chronic kidney disease, Computed tomography, Renal papillary density
© 2015 Yeoh et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Chronic kidney disease (CKD) is an important pub-
lic health problem that affects 10–15  % of adults in the 
United States [1, 2]. CKD is independently associated 
with cardiovascular disease (CVD) and an increased 
risk of mortality [3, 4]. Identification of the risk factors 
associated with CKD earlier in the progression of the 
disease could help elucidate the mechanism of CKD 
development and shed light on potential target inter-
ventions that could delay progression and reduce future 
complications.
Renal papillary calcification is a potential candidate 
risk factor for CKD. Nephrolithiasis is an independent 
risk factor for CKD and end-stage renal disease [5, 6]. 
Biopsies of renal papillary tissue in patients with nephro-
lithiasis show that even modest, subclinical calcification 
is associated with interstitial fibrosis, tubular obstruc-
tion and scarring [7, 8]. Renal papillary density (RPD) 
assessed with computed tomography (CT) is a potential 
marker of papillary calcification. Substantially higher 
RPD was observed in individuals with a history of kidney 
stones and RPD is a risk factor for future kidney stones 
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[9–12]. Notably, biopsy-verified papillary calcification 
and increased RPD are observed in both unaffected and 
affected kidneys of individuals with nephrolithiasis [12]. 
These findings suggest that increased renal papillary 
calcification can arise in the absence of clinical kidney 
stones and is suggestive of systemic metabolic derange-
ments. Thus, RPD may be an ideal, non-invasive surro-
gate marker for renal papillary calcification.
The feasibility and reproducibility of measuring RPD 
using CT has not been well studied. A robust technique 
for an accurate, non-invasive measurement of RPD could 
provide important information about current kidney 
health and provide greater information about the risk of 
developing CKD. We aimed to develop a novel reproduc-
ible protocol to measure RPD using CT scans in partici-
pants from the Framingham Heart Study cohort.
Results
Study sample characteristics
Of the 100 participants in the reproducibility sample, 
six were excluded due poor image quality or the lack of 
visible kidney sinus. Characteristics of the remaining 94 
participants are presented in Table  1. The sample was 
47 % women and the mean age was 59.9 ± 13.0 years. The 
mean BMI was 27.8 ± 4.6. The mean RPD measurement 
for the first reader was 48.7 ± 4.7 HU (range 38.7–61.7).
Intra‑ and inter‑reader reproducibility
Intra- and inter-reader RPD measurement comparisons 
are plotted in Fig. 1a, b, respectively. For our single slice 
protocol, the intra-reader intra-class correlation coeffi-
cient was 0.86 while the inter-class correlation was 0.79.
The Bland–Altman comparison of the intra-reader 
repeated measurements is presented in Fig. 2a. The over-
all mean difference was 0.98 with lower and upper 95 % 
confidence intervals of 0.47 and 1.50, respectively. Pit-
man’s Test of Difference in Variance showed no system-
atic bias between intra-reader repeated measurements 
(p  =  0.66). The Bland–Altman plot of the inter-reader 
measurements is presented in Fig. 2b. The overall mean 
difference between the two readers was 0.043 (95  % CI 
−0.59 to 0.67). Pitman’s Test of Difference in variance 




Using a representative sample from the Framingham 
Heart Study cohort, we have demonstrated the feasibility 
and reproducibility of measuring RPD using CT, a non-
invasive marker of papillary calcification, with high intra- 
and inter-reader correlation.
Table 1 Characteristics of  participants at  the baseline 
examination
Risk factor Mean/Median/N SD/IQR/%
Female 46 47 %
Age, years 59.9 13.0
Diabetes mellitus 10 10.2 %
Systolic blood pressure, mmHg 125.5 16.7
Diastolic blood pressure, mmHg 73.9 9.8
Hypertension Rx 32 32.7 %
Hypertension 38 38.8 %
BMI, kg/m2 27.8 4.6
HDL cholesterol, mg/ml 52.6 14.3
Triglycerides, mg/ml 124.9 76.0–163.0
Current smoker 12 12.2 %
eGFR, ml/min/1.73 m2 83.8 20.4
Dipstick proteinuria 13 13.5 %
Prevalent CKD 5 5.2




















































35.00 40.00 45.00 50.00 55.00 60.00 65.00












































35.00 40.00 45.00 50.00 55.00 60.00 65.00
Mean Renal Papillary Density (HU) Reader 1 Measurement 2
a
b
Fig. 1 Plot comparing the mean RPD for the intra-reader replication 
(a) and inter-reader replication (b). Linear regression of mean RPD for 
intra-reader and inter-reader measurements. Intra-class correlation 
coefficients were 0.86 and 0.79 respectively
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In the context of the current literature
CT has been used to assess RPD in prior studies and it 
has long been known that there is considerable vari-
ability in RPD between individuals [13, 14]. It has been 
demonstrated that RPD is increased in individuals with 
kidney stones [9, 10, 12] and in those who later develop 
nephrolithiasis [11], suggesting that it has some utility 
as a biomarker of kidney stone risk. Although there are 
no studies directly comparing histologic findings with 
CT appearance, it has been proposed that the increased 
density noted in these individuals represents micro-
calcification of the papillae which is both known to be 
associated with an increased risk of kidney stones and is 
a risk factor for local inflammation, fibrosis and nephron 
loss [7, 8, 15]. Papillary density has been shown to change 
in the setting of unilateral ureteral obstruction [16] and 
malignancy [13] and CT attenuation has been used to 
distinguish between various histologic subtypes of renal 
masses [17, 18]. However, techniques to measure RPD 
are not standardized across studies. Our study seeks to 
extend the field by demonstrating the reproducibility of a 
simple technique to measure RPD in a population-based 
sample.
Using the MDCT study data, other groups from the 
Framingham Heart Study have described novel, repro-
ducible techniques for measuring renal sinus fat [19], 
liver fat [20], left atrial size [21] and visceral adipose 
tissue [22]. The results of our study compare favorably 
with these results and suggest that this technique could 
be applied successfully to a larger cohort of individuals 
in order to investigate a potential role as a biomarker of 
CKD risk.
Implications
Our study demonstrates the feasibility of a protocol to 
measure RPD using CT. RPD may be an important meas-
urement to assess kidney health and may provide impor-
tant information about an individual’s risk of developing 
CKD. Future studies will include applying this RPD pro-
tocol to a larger sample size to investigate associations 
between RPD with CVD and CKD risk factors.
Strengths and limitations
A major strength of this study is our RPD measurement 
protocol that is easily performed and easily applied to 
abdominal CT scan data. One limitation is the ethnic 
homogeneity (primarily non-Hispanic White) of the 
Framingham Heart Study which may limit the general-
izability of our findings to other populations. Another 
limitation is a lack of renal papillary biopsy to correlate 
with our RPD measurements. Finally, prior studies have 
shown that RPD may correlate with hydration status and 
the urinary specific gravity [16, 23]. No specific proto-
col was followed for hydration prior to the CT scans and 
simultaneous urine studies were not performed. Thus we 
cannot account for the effect of hydration on the results 
of these measurements.
Conclusion
We have developed a novel protocol to asses RPD by CT 
and have shown that this measurement has high intra- 
and inter-reader reproducibility. Applying this proto-
col to larger cohorts will provide important information 




The participants in this study were derived from the 
Framingham Heart Study CT sub-study. The Original 































































Fig. 2 Bland–Altman plot showing the intra-reader and inter-reader 
repeated RPD measurements. The mean difference between the two 
intra-reader reads was 0.98 (95 % CI 0.47–1.50). Pitman’s test of differ-
ence in variance was negative suggesting little bias (p = 0.66) (a). The 
mean difference between the two inter-reader reads was 0.04 (95 % 
CI −0.59 to 0.67). Pitman’s test of difference in variance was negative 
(p = 0.64) (b)
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children’s spouses were enrolled in the Offspring cohort 
in 1971 and the Third Generation cohort, with at least 
one parent in the Offspring cohort, were enrolled in 
2002 [24, 25]. The Framingham multi-detector computed 
tomography (MDCT) sub-cohort primarily contains 
individuals living in the New England area. Participants 
were qualified if they were female (>40  years old) and 
not pregnant, male (>35  years old), and had a body 
weight <160 kg. Between 2002 and 2005, a total of 3539 
MDCT participants from the Offspring (n =  1422) and 
Third Generation cohorts (n  =  2117) underwent an 
MDCT scan as previously described [22]. A sample of 
100 participants from the Offspring Cohort were ran-
domly selected for equal representation of age (35–44, 
45–54, 55–64, 65–74, and 75–84  years old) and sex 
strata. Informed consent was required of each participant 
and this study was approved by the Massachusetts Gen-
eral Hospital and Boston Medical Center Institutional 
Review Boards and met the terms of the Declaration of 
Helsinki.
MDCT scan acquisition
Non-contrast abdominal MDCT scans were captured 
with an 8-slice MDCT scanner (LightSpeed Ultra, Gen-
eral Electric; Milwaukee, WI, USA) covering 125 mm of 
the abdomen with 60 consecutive 2.5 mm slices above the 
S1 level (120kVp, 400 mA, gantry rotation time 500 ms, 
table feed 3:1). MDCT scans were managed and assessed 
on the Aquarius 3D Workstation (TeraRecon Inc, San 
Mateo, CA, USA).
Protocol development
The abdominal MDCT scans were initially collected to 
measure abdominal aortic calcification. For this reason, 
the entire kidneys were not fully visualized in all of our 
participants. Because the lower position of the right kid-
ney below the liver was better captured by the abdomi-
nal MDCT scans, we chose the right kidney for all RPD 
measurements.
RPD was measured in a single axial slice. In order to 
choose the optimal slice for reproducibility, we viewed 
consecutive 2.5  mm slices and selected the image with 
the largest amount of renal sinus fat. We avoided slices 
that had obvious kidney stones, neoplasia or cysts. Next, 
we centered the display on the right kidney and magni-
fied the image to 4×. We then used a measurement tool 
to draw three ellipses of approximately 20  ±  2  mm2. 
Using the ellipses, we located three areas in the anterior, 
lateral and posterior part of the slice.
Preference for exact ellipse placement was based on 
four major criteria. First, preference was given to areas in 
which there was indentation of the renal papillary tissue 
into the sinus. Second, we maximized the value of mean 
Hounsfield unit in the ellipse for each region. Third, we 
avoided the inclusion of renal sinus fat (−195 to −45 
HU range). Finally, ellipses had a minimum distance of 
at least 5 mm between them, to prevent resampling the 
same area. We recorded the slice number and the three 
measurements from the slice. The mean value of the 
three measurements was reported and used as the final 
measure going forward.
Statistical analysis
RPD was measured in a single slice by two readers (GM, 
AJY) to determine inter-reader reproducibility. The first 
reader repeated all measurements to assess intra-reader 
reproducibility. Intra- and inter-reader reproducibility 
was evaluated with intra-class correlation coefficients. 
Bland–Altman plots were used to determine any poten-
tial systematic bias within the intra-reader and inter-
reader repeated measurements. All statistical analyses 
were conducted using SAS Version 9.2 (SAS Institute Inc; 
Cary, NC, USA) or STATA Version 12 (StataCorp LP; 
College Station, TX, USA).
Abbreviations
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